HIF1A and neoplasm: Small molecules including EZN-2968, Topotecan, PX-478, 2-methoxyestradiol, and KC7F2 that inhibit HIF-1α have been developed because tumor hypoxia stabilizes the HIF-1α engaged in VEGF expression and chemoresistance in many solid tumors (Yu et al. 2017).